Tiverton Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-884
Closed -$1.67M 495
2018
Q3
$1.67M Sell
884
-309
-26% -$638K 0.08% 153
2018
Q2
$2.43M Sell
1,193
-167
-12% -$381K 0.12% 125
2018
Q1
$3.01M Sell
1,360
-413
-23% -$1.05M 0.21% 101
2017
Q4
$4.09M Sell
1,773
-371
-17% -$753K 0.26% 92
2017
Q3
$3.81M Sell
2,144
-109
-5% -$152K 0.22% 114
2017
Q2
$3.06M Buy
2,253
+129
+6% +$156K 0.17% 136
2017
Q1
$2.5M Hold
2,124
0.13% 152
2016
Q4
$1.7M Hold
2,124
0.1% 167
2016
Q3
$1.86M Sell
2,124
-35,412
-94% -$25.7M 0.15% 132
2016
Q2
$12.9M Buy
37,536
+30,348
+422% +$17.2M 0.54% 64
2016
Q1
$3.96M Buy
+7,188
New +$4.41M 0.13% 118

Other funds holding BLUE

Tiverton Asset Management's BLUE Position: Q4 2018 in Review

Tiverton Asset Management sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 884 shares — an estimated $1.67M sold.

Tiverton Asset Management first reported a position in BLUE in Q1 2016 and held it in 11 quarters. The position peaked at $12.9M in Q2 2016. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Tiverton Asset Management reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 884 bluebird bio shares in Q4 2018, an estimated $1.67M.
  • Tiverton Asset Management first reported a position in bluebird bio in Q1 2016 and held it in 11 quarters.
  • Tiverton Asset Management's bluebird bio position peaked at $12.9M in Q2 2016.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Tiverton Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.